• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CME Group Inc. Reports Fourth Consecutive Year of Record Annual Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for 2025

    2/4/26 7:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance
    Get the next $CME alert in real time by email
    • Record annual revenue of $6.5 billion, up 6%
    • Record annual market data revenue of $803 million, up 13%

    CHICAGO, Feb. 4, 2026 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today reported financial results for the fourth quarter and full year of 2025.

    The company reported revenue of $1.6 billion and operating income of $1.0 billion for the fourth quarter of 2025. Net income was $1.2 billion and diluted earnings per common share were $3.24. On an adjusted basis, net income was $1.0 billion and diluted earnings per common share were $2.77. Financial results presented on an adjusted basis for the fourth quarter of 2025 and 2024 exclude certain items, which are detailed in the reconciliation of non-GAAP results.1

    Total revenue for full-year 2025 was $6.5 billion and operating income was $4.2 billion. Net income was $4.1 billion and diluted earnings per common share were $11.16. On an adjusted basis, net income was $4.1 billion, and diluted earnings per common share were $11.20.

    "Last year, CME Group delivered the best year in our history and our fourth consecutive year of record revenue, adjusted operating income, adjusted net income and adjusted earnings per share," said Terry Duffy, CME Group Chairman and Chief Executive Officer. "In a risk-always-on environment, client demand for our products and services generated record average daily volume of 28.1 million contracts, including 12% growth in commodities trading and a 5% increase in financials. In Q4, we achieved the second-highest quarterly revenue in our history as well as the highest Q4 volume on record. Looking ahead, we're focused on further increasing the $80 billion in average daily margin efficiencies we provided our market users in Q4, as well as expanding access through initiatives such as U.S. Treasury clearing, 24/7 cryptocurrency trading and prediction markets."

    1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of Adjusted Operating Income and Adjusted Net Income and Adjusted Diluted Earnings per Common Share charts at the end of the financial statements. 

    Fourth-quarter 2025 average daily volume (ADV) was the all-time highest fourth quarter with 27.4 million contracts, up 7% from fourth-quarter 2024. Non-U.S. ADV reached 8.3 million contracts, up 9% compared with the same period in 2024, including Asia up 18% and EMEA up 6%.

    Clearing and transaction fees revenue for fourth-quarter 2025 totaled $1.3 billion. The total average rate per contract was $0.707. Market data revenue totaled $208 million for fourth-quarter 2025.

    As of December 31, 2025, the company had approximately $4.6 billion in cash (including $200 million deposited with Fixed Income Clearing Corporation (FICC) and included in other current assets) and $3.4 billion of debt. The company paid dividends of approximately $3.9 billion in 2025. The company has returned nearly $30 billion to shareholders in the form of dividends since the implementation of the variable dividend policy in early 2012.

    CME Group will hold a Q&A conference call to discuss fourth-quarter 2025 results at 8:30 a.m. Eastern Time today.  A live audio webcast of the Q&A call will be available on the Investor Relations section of CME Group's website at investor.cmegroup.com.  An archived recording will be available for up to two months after the call.

    As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing. 

    CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and, E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec and EBS are trademarks of BrokerTec Europe LTD and EBS Group LTD, respectively. The S&P 500 Index is a product of S&P Dow Jones Indices LLC ("S&P DJI"). "S&P®", "S&P 500®", "SPY®", "SPX®", US 500 and The 500 are trademarks of Standard & Poor's Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners.

    Statements in this press release that are not historical facts are forward-looking statements.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking statements. Except as required by the federal securities laws, we undertake no obligation to update any forward-looking statement, release publicly any revisions to any forward-looking statements or report the occurrence of unanticipated events, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our ability to continue introducing innovative and competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and derive revenues that are commensurate with our efforts and expectations, and our ability to maintain the competitiveness of our existing products and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to manage variable costs relating to CME Group's transition to the Google Cloud and minimize duplicative costs during the transition between maintaining the on-premise environment and the Google Cloud environment; the resilience of our electronic platforms and the soundness of our business continuity and disaster recovery plans, including in the event of cyberattacks and cyberterrorism or as impacted by a failure of or disruption at one of our suppliers; our ability to maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers; our ability to expand and globally offer our products and services; changes in regulations, including the impact of any changes in laws or government policies with respect to our products or services or our industry, such as any changes to regulations and policies that require increased financial and operational resources from us or our customers, as well as the impact of tariffs and tax policy changes and the related uncertainty thereof, restrictions on our ability to offer CME Group products and services in specific geographies or to specific customers or limitations or changes in underlying/physical product flows across geographies; the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others; decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions; changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our credit and liquidity risk management practices to adequately protect us from the credit risks of clearing members and other counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk management programs to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets; our dependence on third-party providers and exposure to risk through third parties, including risks related to the performance, reliability and security of technology used by, or facilities provided by, our third-party providers and third-party providers that our clients and third-parties rely on; our reliance on third-party distribution partners, including independent software vendors (ISVs), Futures Commission Merchants (FCMs), introducing brokers, broker-dealers, regulatory reporting and data distributors and platform operators, and other partners, for facilitating trading and for market data information, and potential impacts from changes in their business models and priorities; volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and instruments such as interest rates, equity indices, fixed income instruments and foreign exchange rates; economic, social, political and market conditions, including new and existing geopolitical tensions or conflicts, the volatility of the capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers; our ability to accommodate increases in contract volume and market data and order transaction traffic across the entire trade cycle and the ability to implement enhancements meeting our regulatory obligations and customer needs without failure or degradation of the performance of our trading and clearing systems; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks, control the costs and achieve the synergies associated with and benefits from our strategy for acquisitions, investments and alliances, strategic partnerships and joint ventures; variances in earnings on cash accounts and collateral that our clearing house holds; impact of CME Group pricing/fee level and structure and incentive changes; impact of aggregation services and internalization on trade flow and volumes; any negative financial impacts from changes to the terms of intellectual property and index rights; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business; industry, channel partner and customer consolidation and/or concentration; decreases in trading and clearing activity; the imposition of a transaction tax or user fee on futures and options transactions and/or repeal of the 60/40 tax treatment of such transactions; increases in effective tax rates, borrowing costs, or changes in tax policy; our ability to maintain our brand and reputation; and the unfavorable resolution of material legal proceedings.  For a detailed discussion and additional information concerning these and other factors that might affect our performance, see our other recent periodic filings, including our Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the Securities and Exchange Commission ("SEC") on February 27, 2025, under the caption "Risk Factors".

    CME Group Inc. and Subsidiaries

    Consolidated Balance Sheets

    (in millions)







    December 31, 2025



    December 31, 2024

    ASSETS









    Current Assets:









    Cash and cash equivalents



    $                 4,416.9



    $                 2,892.4

    Marketable securities



    125.0



    113.2

    Accounts receivable, net of allowance



    639.2



    573.1

    Other current assets (includes $6.5 and $6.3 in restricted cash)



    522.1



    559.4

    Performance bonds and guaranty fund contributions



    159,656.1



    98,895.4

    Total current assets



    165,359.3



    103,033.5

    Property, net of accumulated depreciation and amortization



    362.7



    386.2

    Intangible assets—trading products



    17,175.3



    17,175.3

    Intangible assets—other, net



    2,610.7



    2,821.6

    Goodwill



    10,514.7



    10,486.9

    Other assets



    2,401.5



    3,543.5

    Total Assets



    $             198,424.2



    $             137,447.0

    LIABILITIES AND EQUITY









    Current Liabilities:









    Accounts payable



    $                       71.8



    $                       79.9

    Short-term debt



    —



    749.8

    Other current liabilities



    568.8



    2,588.8

    Performance bonds and guaranty fund contributions



    159,656.1



    98,895.4

    Total current liabilities



    160,296.7



    102,313.9

    Long-term debt



    3,422.3



    2,678.2

    Deferred income tax liabilities, net



    5,242.2



    5,246.8

    Other liabilities



    734.8



    721.2

    Total Liabilities



    169,696.0



    110,960.1

    CME Group Shareholders' Equity



    28,728.2



    26,486.9

    Total Liabilities and Equity



    $             198,424.2



    $             137,447.0

     

    CME Group Inc. and Subsidiaries

    Consolidated Statements of Income

    (dollars in millions, except per share amounts; shares in thousands)







    Quarter Ended

    December 31,



    Year Ended

    December 31,







    2025



    2024



    2025



    2024



    Revenues



















    Clearing and transaction fees



    $    1,327.9



    $    1,232.3



    $    5,281.1



    $    4,988.2



    Market data and information services



    208.0



    181.6



    803.1



    710.2



    Other



    112.8



    111.4



    436.4



    431.7



    Total Revenues



    1,648.7



    1,525.3



    6,520.6



    6,130.1



    Expenses



















    Compensation and benefits



    241.1



    220.8



    907.0



    850.3



    Technology



    75.2



    65.7



    283.2



    255.8



    Professional fees and outside services



    47.9



    33.9



    150.5



    132.7



    Amortization of purchased intangibles



    55.9



    55.3



    223.4



    221.7



    Depreciation and amortization



    26.5



    28.1



    107.5



    115.1



    Licensing and other fee agreements



    96.6



    84.0



    371.0



    355.4



    Other



    85.9



    90.4



    248.5



    267.6



    Total Expenses



    629.1



    578.2



    2,291.1



    2,198.6



    Operating Income



    1,019.6



    947.1



    4,229.5



    3,931.5



    Non-Operating Income (Expense)



















    Investment income



    1,776.7



    936.5



    5,736.5



    4,079.1



    Interest and other borrowing costs



    (43.7)



    (40.7)



    (173.4)



    (160.9)



    Equity in net earnings (losses) of unconsolidated

    subsidiaries



    88.2



    91.2



    371.7



    350.9



    Other non-operating income (expense)



    (1,262.4)



    (837.5)



    (4,833.8)



    (3,659.2)



    Total Non-Operating Income (Expense)



    558.8



    149.5



    1,101.0



    609.9



    Income before Income Taxes



    1,578.4



    1,096.6



    5,330.5



    4,541.4



    Income tax provision



    395.5



    222.0



    1,258.3



    1,015.6



    Net Income



    $    1,182.9



    $       874.6



    $    4,072.2



    $    3,525.8



    Net Income Attributable to Common Shareholders of

    CME Group



    $    1,168.0



    $       863.7



    $    4,021.0



    $    3,481.5























    Earnings per Share Attributable to Common Shareholders of CME Group:



    Basic



    $         3.25



    $         2.40



    $       11.18



    $          9.69



    Diluted



    3.24



    2.40



    11.16



    9.67



    Weighted Average Number of Common Shares:



















    Basic



    359,633



    359,568



    359,648



    359,389



    Diluted



    360,233



    360,050



    360,310



    359,944



     

    CME Group Inc. and Subsidiaries

    Reconciliation of Adjusted Operating Income

    (dollars in millions)























    Quarter Ended

    December 31,



    Year Ended

    December 31,





    2025



    2024



    2025



    2024

    Total Revenues



    $    1,648.7



    $    1,525.3



    $  6,520.6



    $  6,130.1

    Real estate-related (costs) credits



    —



    (0.1)



    —



    (1.0)

    Adjusted Total Revenues



    $    1,648.7



    $    1,525.2



    $  6,520.6



    $  6,129.1



















    Total Expenses



    $       629.1



    $       578.2



    $  2,291.1



    $  2,198.6

    Restructuring and severance



    (5.8)



    (1.0)



    (14.8)



    (11.3)

    Deferred compensation(1)



    (2.6)



    (0.9)



    (14.2)



    (15.9)

    Amortization of purchased intangibles



    (55.9)



    (55.3)



    (223.4)



    (221.7)

    Strategic transaction-related (costs) credits



    (19.6)



    —



    (23.6)



    (0.8)

    Real estate-related (costs) credits



    (0.7)



    —



    6.7



    1.1

    Foreign exchange transaction gains (losses)



    (1.0)



    (0.7)



    (6.1)



    (2.9)

    Unrealized and realized gains (losses) on assets



    (0.1)



    (0.1)



    (0.5)



    (0.9)

    Litigation matters or settlements



    —



    —



    (19.4)



    (1.2)

    Adjusted Total Expenses



    $       543.4



    $       520.2



    $  1,995.8



    $  1,945.0



















    Operating Income



    $    1,019.6



    $       947.1



    $  4,229.5



    $  3,931.5



















    Adjusted Operating Income



    $    1,105.3



    $    1,005.0



    $  4,524.8



    $  4,184.1



















    1. Includes $2.6 million and $14.2 million for a change in our non-qualified deferred compensation liability in the fourth quarter and full-year 2025. This impact does not affect net income or adjusted net income, as the compensation and benefits change has an equal and offsetting change in investment income.

     

    CME Group Inc. and Subsidiaries

    Reconciliation of Adjusted Net Income and Adjusted Diluted Earnings per Common Share

    (dollars in millions, except per share amounts; shares in thousands)























    Quarter Ended

    December 31,



    Year Ended

    December 31,





    2025



    2024



    2025



    2024

    Net Income



    $     1,182.9



    $         874.6



    $    4,072.2



    $     3,525.8

    Restructuring and severance



    5.8



    1.0



    14.8



    11.3

    Amortization of purchased intangibles(1)



    62.7



    69.0



    269.9



    275.9

    Strategic transaction-related costs(2)



    25.3



    —



    31.8



    0.8

    Real estate-related costs (credits)



    0.7



    —



    (6.7)



    (2.0)

    Foreign exchange transaction (gains) losses



    1.0



    0.7



    6.1



    2.9

    Unrealized and realized (gains) losses on investments



    (349.8)



    8.1



    (343.7)



    (3.6)

    Unrealized and realized (gains) losses on assets



    0.1



    0.1



    0.5



    0.9

    Litigation matters or settlements



    —



    —



    19.4



    1.2

    Income tax effect related to above



    52.7



    (15.9)



    2.9



    (57.2)

    Other income tax items(3)



    29.0



    (18.7)



    20.9



    (16.8)

    Adjusted Net Income



    $     1,010.4



    $         918.9



    $    4,088.1



    $     3,739.2



















    Adjusted Net Income Attributable to Common

    Shareholders of CME Group



    $         997.7



    $         907.4



    $    4,036.7



    $     3,692.2



















    Earnings per Share Attributable to Common Shareholders of CME Group:

         Basic



    $           3.25



    $           2.40



    $        11.18



    $           9.69

         Diluted



    3.24



    2.40



    11.16



    9.67



















    Adjusted Earnings per Share Attributable to Common Shareholders of CME Group:

         Basic



    $           2.77



    $           2.52



    $        11.22



    $         10.27

    Diluted



    2.77



    2.52



    11.20



    10.26



















    Weighted Average Number of Shares:

















         Basic common shares



    359,633



    359,568



    359,648



    359,389

         Diluted common shares



    360,233



    360,050



    360,310



    359,944

         Preferred shares(4)



    4,584



    4,584



    4,584



    4,584



















    1. Includes $3.7 million and $36.1 million of amortization of purchased intangibles (net of tax) at OSTTRA (for activity prior to the divestment) and $2.6 million and $10.0 million of amortization of purchased intangibles at S&P Dow Jones Indices LLC and $0.5 million of amortization of purchased intangibles at FanDuel Prediction Markets Holdings LLC in the fourth quarter and full-year 2025. This is reported in Equity in net earnings of unconsolidated subsidiaries on the Consolidated Statements of Income.

    2. The values shown above may differ from what is shown in the Reconciliation of Adjusted Operating Income as that schedule does not include adjustment items or portions of items included in non-operating results.

    3. Other income tax items include expense recognized for changes in state and local deferred tax rates and for the settlement of various tax audits.

    4. Preferred shares have similar rights as common shares without voting rights.

     

    CME Group Inc. and Subsidiaries

    Quarterly Operating Statistics







    4Q 2024



    1Q 2025



    2Q 2025



    3Q 2025



    4Q 2025

    Trading Days



    64



    61



    62



    64



    64

     

    Quarterly Average Daily Volume (ADV)(1)

    CME Group ADV (in thousands)



    Product Line



    4Q 2024



    1Q 2025



    2Q 2025



    3Q 2025



    4Q 2025

    Interest rates



    13,244



    15,029



    15,472



    13,378



    13,010

    Equity indexes



    6,343



    7,997



    7,661



    6,278



    7,738

    Foreign exchange



    969



    1,149



    1,096



    834



    853

    Energy



    2,519



    2,903



    3,082



    2,295



    2,523

    Agricultural commodities



    1,755



    1,958



    1,964



    1,712



    1,787

    Metals



    673



    732



    943



    825



    1,441

    Total



    25,503



    29,768



    30,217



    25,322



    27,353

    Venue





















    CME Globex



    23,684



    27,732



    28,097



    23,418



    25,542

    Open outcry



    848



    881



    993



    989



    816

    Privately negotiated



    971



    1,154



    1,127



    915



    995

    Total



    25,503



    29,768



    30,217



    25,322



    27,353

     

    Quarterly Average Rate Per Contract (RPC)(1)

    CME Group RPC



    Product Line



    4Q 2024



    1Q 2025



    2Q 2025



    3Q 2025



    4Q 2025

    Interest rates



    $          0.485



    $          0.476



    $          0.481



    $          0.487



    $          0.486

    Equity indexes



    0.658



    0.624



    0.635



    0.652



    0.611

    Foreign exchange



    0.778



    0.762



    0.772



    0.841



    0.847

    Energy



    1.237



    1.222



    1.138



    1.214



    1.245

    Agricultural commodities



    1.359



    1.376



    1.435



    1.423



    1.427

    Metals



    1.530



    1.588



    1.456



    1.505



    1.295

    Average RPC



    $          0.701



    $          0.686



    $          0.690



    $          0.702



    $          0.707























    1. ADV and RPC includes futures and options on futures only.

     

    CME-G

    Cision View original content:https://www.prnewswire.com/news-releases/cme-group-inc-reports-fourth-consecutive-year-of-record-annual-revenue-adjusted-operating-income-adjusted-net-income-and-adjusted-earnings-per-share-for-2025-302678360.html

    SOURCE CME Group

    Get the next $CME alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CME

    DatePrice TargetRatingAnalyst
    1/14/2026$305.00Hold → Buy
    TD Cowen
    10/23/2025$300.00Hold → Buy
    Deutsche Bank
    9/25/2025$300.00Neutral → Buy
    Citigroup
    7/24/2025$305.00Buy → Neutral
    UBS
    4/8/2025$301.00Equal-Weight → Overweight
    Morgan Stanley
    3/10/2025$287.00Mkt Perform → Outperform
    Raymond James
    1/6/2025$255.00 → $250.00Buy → Neutral
    Citigroup
    10/8/2024$244.00Buy → Neutral
    Redburn Atlantic
    More analyst ratings

    $CME
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CME Group upgraded by TD Cowen with a new price target

    TD Cowen upgraded CME Group from Hold to Buy and set a new price target of $305.00

    1/14/26 8:20:33 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded CME Group from Hold to Buy and set a new price target of $300.00

    10/23/25 9:04:53 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group upgraded by Citigroup with a new price target

    Citigroup upgraded CME Group from Neutral to Buy and set a new price target of $300.00

    9/25/25 8:21:50 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    SEC Filings

    View All

    CME Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - CME GROUP INC. (0001156375) (Filer)

    2/4/26 7:06:41 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - CME GROUP INC. (0001156375) (Filer)

    2/2/26 9:31:15 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 10-Q filed by CME Group Inc.

    10-Q - CME GROUP INC. (0001156375) (Filer)

    10/24/25 2:07:37 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Shepard William R bought $73,008 worth of Common Stock Class A (262 units at $278.37), increasing direct ownership by 0.45% to 2,477 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    1/2/26 2:30:36 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    Director Shepard William R bought $72,672 worth of Common Stock Class A (274 units at $265.19), increasing direct ownership by 0.47% to 2,466 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    9/26/25 8:46:02 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    Director Shepard William R was granted 879 units of Common Stock Class A and bought $72,336 worth of Common Stock Class A (267 units at $270.53), increasing direct ownership by 0.46% to 2,455 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    6/26/25 6:11:41 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CME Group Inc. Reports Fourth Consecutive Year of Record Annual Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for 2025

    Record annual revenue of $6.5 billion, up 6%Record annual market data revenue of $803 million, up 13%CHICAGO, Feb. 4, 2026 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today reported financial results for the fourth quarter and full year of 2025. The company reported revenue of $1.6 billion and operating income of $1.0 billion for the fourth quarter of 2025. Net income was $1.2 billion and diluted earnings per common share were $3.24. On an adjusted basis, net income was $1.0 billion and diluted earnings per common share were $2.77. Financial results presented on an adjusted basis for the fourth quarter of 2025 and 2024 exclude certain items, which are detailed in the reconciliation of non-G

    2/4/26 7:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group January Volume Sets New Record of 29.6 Million Contracts, Up 15% Year Over Year

    Record ADV in metals productsRecord ADV in Henry Hub Natural Gas, Micro Silver and Micro Copper contractsHighest-ever January ADV in interest rate and energy productsCHICAGO, Feb. 3, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its highest January average daily volume (ADV) on record at 29.6 million contracts, an increase of 15% year-over-year. The company's previous January ADV record was set in 2025 with 25.7 million contracts. Market statistics are available in greater detail at https://cmegroupinc.gcs-web.com/monthly-volume. January 2026 ADV across asset classes includes: Interest Rate ADV of 13.9 million contractsEquity Index ADV of 7.3 mi

    2/3/26 7:30:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Named as First-Ever Chicago White Sox Jersey Patch Sponsor

    Iconic Chicago Institutions Team Up for Multiyear Agreement Reaching Global Audiences CHICAGO, Jan. 28, 2026 /PRNewswire/ -- The Chicago White Sox today announced a multiyear agreement establishing CME Group, the world's leading derivatives marketplace, as the team's inaugural jersey patch sponsor and Official Global Exchange Partner. Under the terms of the deal, the CME Group logo will be featured on the home, road and alternate jerseys, including the MLB Nike City Connect uniform, for all Spring Training, regular and postseason games. In addition to the jersey patch, CME Group receives prominent fixed signage behind home plate during home games at Rate Field, as well as other promotional

    1/28/26 11:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Shepard William R bought $73,008 worth of Common Stock Class A (262 units at $278.37), increasing direct ownership by 0.45% to 2,477 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    1/2/26 2:30:36 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    Chairman and CEO Duffy Terrence A covered exercise/tax liability with 10,210 units of Common Stock Class A, decreasing direct ownership by 16% to 55,594 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    1/2/26 2:28:35 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    Chairman and CEO Duffy Terrence A sold $6,738,815 worth of Common Stock Class A (25,000 units at $269.55), decreasing direct ownership by 28% to 65,804 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    12/15/25 3:05:24 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Leadership Updates

    Live Leadership Updates

    View All

    Leading Financial Institutions to Join BrokerTec Chicago for First Day of Trading

    New Central Limit Order Book for U.S. Treasury Trading to Launch Oct. 6CHICAGO, Sept. 4, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that Citigroup, J.P. Morgan and Morgan Stanley will be available to trade cash U.S. Treasuries on BrokerTec Chicago when it launches on October 6. "With leading financial firms on board for day one on BrokerTec Chicago, trading U.S. Treasury futures and cash will be more efficient than ever before," said Mike Dennis, CME Group Global Head of Fixed Income. "CME Group is in a unique position to bring these markets together, unlocking value for our clients worldwide who want to more precisely hedge their risk amid

    9/4/25 8:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Inc. Announces Preliminary Results from its 2025 Annual Meeting of Shareholders

    CHICAGO, May 9, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today announced the preliminary shareholder voting results from its 2025 annual meeting. At the meeting, shareholders: Elected Terrence A. Duffy, Kathryn Benesh, Timothy S. Bitsberger, Charles P. Carey, Bryan T. Durkin, Harold Ford Jr., Martin J. Gepsman, Daniel G. Kaye, Phyllis M. Lockett, Deborah J. Lucas, Rahael Seifu, William R. Shepard, Howard J. Siegel and Dennis A. Suskind, each for a one-year term expiring in 2026.Ratified the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2025.Approved, on an advisory basis, the compensation of our named executive officers.There was

    5/9/25 10:29:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Clearing Appoints New Chief Risk Officer

    CHICAGO, April 24, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced the appointment of Vijay Albuquerque as Chief Risk Officer (CRO) in its Clearing & Post-Trade Services Division.  With over 20 years' industry experience, Albuquerque most recently served as the Head of Counterparty Risk and Portfolio Risk Analytics for Citigroup's Markets and Banking businesses. Albuquerque will be based in New York and will report to Suzanne Sprague, CME Group Chief Operating Officer and Global Head of Clearing. "Vijay's deep expertise in both derivatives and securities markets will be invaluable as we continue to deliver leading risk management services to our

    4/24/25 4:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Financials

    Live finance-specific insights

    View All

    CME Group Inc. Reports Fourth Consecutive Year of Record Annual Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for 2025

    Record annual revenue of $6.5 billion, up 6%Record annual market data revenue of $803 million, up 13%CHICAGO, Feb. 4, 2026 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today reported financial results for the fourth quarter and full year of 2025. The company reported revenue of $1.6 billion and operating income of $1.0 billion for the fourth quarter of 2025. Net income was $1.2 billion and diluted earnings per common share were $3.24. On an adjusted basis, net income was $1.0 billion and diluted earnings per common share were $2.77. Financial results presented on an adjusted basis for the fourth quarter of 2025 and 2024 exclude certain items, which are detailed in the reconciliation of non-G

    2/4/26 7:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Inc. Announces Fourth-Quarter and Year-End 2025 Earnings Release, Conference Call

    CHICAGO, Dec. 17, 2025 /PRNewswire/ -- CME Group Inc. will announce earnings for the fourth quarter and full year of 2025 before the markets open on Wednesday, February 4, 2026. Written highlights for the quarter will be posted on the company's website at 6:00 a.m. Central Time, the same time it provides its earnings press release. The company will also hold an investor conference call that day at 7:30 a.m. Central Time, at which time company executives will take analysts' questions.  A live audio Webcast of the conference call will be available on the Investor Relations section of the company's website. Following the conference call, an archived recording will be available at the same site

    12/17/25 7:30:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Declares Quarterly Dividend

    CHICAGO, Nov. 6, 2025 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today declared a fourth-quarter dividend of $1.25 per share. The dividend is payable December 30, 2025, to shareholders of record as of December 12, 2025. As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, crypto

    11/6/25 7:30:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

    SC 13G/A - CME GROUP INC. (0001156375) (Subject)

    2/13/24 5:02:29 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

    SC 13G/A - CME GROUP INC. (0001156375) (Subject)

    2/13/23 2:49:27 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

    SC 13G/A - CME GROUP INC. (0001156375) (Subject)

    2/11/22 3:04:00 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance